Launch charitable initiatives connecting trial participants with pharmaceutical companies to enhance patient support and access to innovative treatments.
2025 Health Charity Run, co-organized with the
Chinese Pharmaceutical Association, Shanghai Center for Drug Evaluation, and DIA .